Huntsman HUN
NYSE · Chemicals & Allied Products · $1.6BData provided by Databento (end of day). Next close = the first close after a story against the close before it; official daily closes only, not a call, not advice.
The numbers
fiscal 2025, as filed with the SEC · 66-metric EOD snapshot via DatabentoOperating leverage — margins
| Line Item (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | YoY Δ | 4Y CAGR | Trend |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | $7.7B | $8.0B | $6.1B | $6.0B | $5.7B | −5.8% | −7.2% | |
| Cost of Revenue (COGS) | $6.1B | $6.5B | $5.2B | $5.2B | $4.9B | −4.6% | −5.1% | |
| Gross Profit | $1.6B | $1.5B | $906.0M | $866.0M | $751.0M | −13.3% | −17.0% | |
| Research & Development (R&D) | $135.0M | $125.0M | $115.0M | $121.0M | $120.0M | −0.8% | −2.9% | |
| Selling, General & Admin (SG&A) | $739.0M | $711.0M | $689.0M | $671.0M | $670.0M | −0.1% | −2.4% | |
| Total Operating Expenses | $853.0M | $874.0M | $822.0M | $891.0M | $882.0M | −1.0% | +0.8% | |
| Operating Income (EBIT) | $731.0M | $672.0M | $84.0M | $-25.0M | $-131.0M | −424.0% | — | |
| Interest Expense | — | — | — | — | $249.0M | — | — | |
| Income Tax Expense | $191.0M | $186.0M | $64.0M | $61.0M | $26.0M | −57.4% | −39.3% | |
| GAAP Net Income | $1.0B | $460.0M | $101.0M | $-189.0M | $-284.0M | −50.3% | — | |
| Diluted EPS | $4.72 | $2.27 | $0.57 | $-1.10 | $-1.65 | −50.0% | — | |
| Diluted Shares | 221.4M | 203.0M | 177.4M | 172.1M | 172.6M | +0.3% | −6.0% | |
| Balance Sheet | ||||||||
| Cash & Equivalents | $1.0B | $654.0M | $540.0M | $340.0M | $429.0M | +26.2% | −19.9% | |
| Inventory | $1.0B | $995.0M | $867.0M | $917.0M | $818.0M | −10.8% | −5.8% | |
| Total Current Assets | $3.9B | $3.1B | $2.3B | $2.1B | $2.1B | −2.9% | −14.9% | |
| Total Assets | $9.4B | $8.2B | $7.2B | $7.1B | $7.0B | −1.4% | −7.0% | |
| Total Current Liabilities | $2.1B | $1.7B | $1.2B | $1.6B | $1.6B | +1.5% | −6.2% | |
| Total Debt (Short + Long Term) | $1.6B | $1.8B | $1.7B | $2.2B | $2.4B | +9.4% | +10.9% | |
| Total Liabilities | $4.8B | $4.4B | $3.8B | $4.0B | $4.1B | +2.7% | −4.3% | |
| Stockholders' Equity | $4.6B | $3.8B | $3.5B | $3.2B | $3.0B | −6.5% | −10.3% | |
| Net Cash / (Net Debt) | $-521.0M | $-1.1B | $-1.2B | $-1.8B | $-1.9B | −6.3% | — | |
| Invested Capital | $5.1B | $5.0B | $4.6B | $5.0B | $4.9B | −1.8% | −0.9% | |
| Cash Flow & Capital Allocation | ||||||||
| Operating Cash Flow (OCF) | $952.0M | $914.0M | $209.0M | $263.0M | $289.0M | +9.9% | −25.8% | |
| Depreciation & Amortization (D&A) | $278.0M | $281.0M | $278.0M | $289.0M | $287.0M | −0.7% | +0.8% | |
| Stock-Based Compensation (SBC) | $30.0M | $29.0M | $28.0M | $30.0M | $31.0M | +3.3% | +0.8% | |
| Capital Expenditures (CapEx) | $326.0M | $272.0M | $230.0M | $184.0M | $173.0M | −6.0% | −14.6% | |
| Free Cash Flow (FCF) | $626.0M | $642.0M | $-21.0M | $79.0M | $116.0M | +46.8% | −34.4% | |
| True FCF (ex-SBC Owner Cash) | $596.0M | $613.0M | $-49.0M | $49.0M | $85.0M | +73.5% | −38.5% | |
| Share Repurchases (Buybacks) | $200.0M | $1.0B | $349.0M | $4.0M | $0 | −100.0% | — | |
| Dividends Paid | $159.0M | $171.0M | $169.0M | $174.0M | $146.0M | −16.1% | −2.1% | |
Fundamentals, income distribution and multi-year statements from SEC EDGAR filings (public domain). Valuation multiples, performance and technicals computed from Databento 1D EOD closes. For information only, not investment advice.